Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fuster

Showing results (21-30 of 502) with videos related to

Pageof 51
Sort By:
Annales D'Immunologie|May 1, 1982
Immunomodulation with P40, an insoluble delipidated fraction of Corynebacterium granulosum. I.--Immune response to sheep red blood cellsM J Fuster, P H Lagrange
Diabetologia|March 11, 2025
Clonal haematopoiesis of indeterminate potential: an emerging risk factor for type 2 diabetes and related complicationsMaría A Zuriaga, José J Fuster
Ebiomedicine|May 1, 2022
Troublemaking mutations: Clonal hematopoiesis for the prediction of prognosis in ST-segment elevation myocardial infarctionMiriam Díez-Díez, José J Fuster
Atherosclerosis|February 29, 2020
Clonal hematopoiesis driven by somatic mutations: A new player in atherosclerotic cardiovascular diseaseMarta Amorós-Pérez, José J Fuster
Revista Espanola De Cardiologia (English Ed.)|May 13, 2019
Potential Therapeutic Value of Interleukin 1b-targeted Strategies in Atherosclerotic Cardiovascular DiseaseVanesa Viana-Huete, José J Fuster
Revista Chilena De Obstetricia Y Ginecologia|January 1, 1989
[Doppler in 42 high risk pregnancies: predictive values of the flow velocity wave indexes in the arcuate and umbilical arteries]E Guzmán, N Rodríguez, J Fuster
Atherosclerosis|June 15, 2026
Hematopoietic somatic mutations in atherosclerotic cardiovascular diseaseBeatriz L Ramos-Neble, José J Fuster
JAMA Cardiology|August 30, 2025
Clonal Hematopoiesis-Fuel to Inflame the HeartDomingo A Pascual-Figal, Jose J Fuster
JAMA Cardiology|November 9, 2025
Clonal Hematopoiesis-An Opportunity to Confront the Heart Failure EpidemicDomingo A Pascual-Figal, José J Fuster
Journal of Hypertension|October 9, 2007
Telomere dysfunction in hypertensionJosé J Fuster, Javier Díez, Vicente Andrés
Pageof 51

Showing results (21-30 of 502) with videos related to

Sort By:
Pageof 51
Annales D'Immunologie|May 1, 1982
Immunomodulation with P40, an insoluble delipidated fraction of Corynebacterium granulosum. I.--Immune response to sheep red blood cellsM J Fuster, P H Lagrange
Diabetologia|March 11, 2025
Clonal haematopoiesis of indeterminate potential: an emerging risk factor for type 2 diabetes and related complicationsMaría A Zuriaga, José J Fuster
Ebiomedicine|May 1, 2022
Troublemaking mutations: Clonal hematopoiesis for the prediction of prognosis in ST-segment elevation myocardial infarctionMiriam Díez-Díez, José J Fuster
Atherosclerosis|February 29, 2020
Clonal hematopoiesis driven by somatic mutations: A new player in atherosclerotic cardiovascular diseaseMarta Amorós-Pérez, José J Fuster
Revista Espanola De Cardiologia (English Ed.)|May 13, 2019
Potential Therapeutic Value of Interleukin 1b-targeted Strategies in Atherosclerotic Cardiovascular DiseaseVanesa Viana-Huete, José J Fuster
Revista Chilena De Obstetricia Y Ginecologia|January 1, 1989
[Doppler in 42 high risk pregnancies: predictive values of the flow velocity wave indexes in the arcuate and umbilical arteries]E Guzmán, N Rodríguez, J Fuster
Atherosclerosis|June 15, 2026
Hematopoietic somatic mutations in atherosclerotic cardiovascular diseaseBeatriz L Ramos-Neble, José J Fuster
JAMA Cardiology|August 30, 2025
Clonal Hematopoiesis-Fuel to Inflame the HeartDomingo A Pascual-Figal, Jose J Fuster
JAMA Cardiology|November 9, 2025
Clonal Hematopoiesis-An Opportunity to Confront the Heart Failure EpidemicDomingo A Pascual-Figal, José J Fuster
Journal of Hypertension|October 9, 2007
Telomere dysfunction in hypertensionJosé J Fuster, Javier Díez, Vicente Andrés
Pageof 51